Disparities in cancer outcomes shrink but persist, and FDA approval increases access to HPV screening.

by Eric Fitzsimmons

People may be able to wait longer between colonoscopies, and a trial evaluates a less invasive option for treating prostate cancer.

by Thomas Celona

Updated recommendation lowers age for breast cancer screening, and laboratory tests will undergo greater FDA oversight.

by Marci A. Landsmann

Supplemental breast screenings are not covered by Medicare, and researchers develop a treatment option for a form of eye cancer.

by Kevin McLaughlin

A urine test may help grade prostate cancers without biopsies, and states look for savings and better health in palliative care.

by Eric Fitzsimmons

Study finds younger generations are aging faster, putting them at increased risk for cancer, and swapping the order of breast cancer treatments could improve patient care.

by Thomas Celona

More cancer patients are enrolling in clinical trials, and sentinel node biopsies alone may be adequate for some early-stage breast cancers.

by Marci A. Landsmann

Survival rates have increased for older AML patients who receive stem cell transplants, and cervical cancer diagnoses rise among women living in low-income counties.

by Kevin McLaughlin

First CAR T-cell therapy approval in chronic lymphocytic leukemia, and Environmental Protection Agency announces a complete ban on asbestos use in manufacturing.

by Thomas Celona

Modified CAR T-cell therapy shows promise in glioblastoma, and an immunotherapy may soon be available as an injection.

by Eric Fitzsimmons